vs

Side-by-side financial comparison of CME Group (CME) and AMDOCS LTD (DOX). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.3B, roughly 1.5× AMDOCS LTD). AMDOCS LTD runs the higher net margin — 11.2% vs 0.1%, a 11.2% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 1.1%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs 4.5%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Amdocs Limited is a multinational telecommunications technology company headquartered in Chesterfield, Missouri. The company specializes in software and services for communications, media and financial services providers and digital enterprises. Amdocs was founded in 1982 and is publicly traded on the Nasdaq stock exchange.

CME vs DOX — Head-to-Head

Bigger by revenue
CME
CME
1.5× larger
CME
$1.9B
$1.3B
DOX
Growing faster (revenue YoY)
CME
CME
+13.3% gap
CME
14.5%
1.1%
DOX
Higher net margin
DOX
DOX
11.2% more per $
DOX
11.2%
0.1%
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
4.5%
DOX

Income Statement — Q1 FY2026 vs Q3 FY2024

Metric
CME
CME
DOX
DOX
Revenue
$1.9B
$1.3B
Net Profit
$1.2M
$140.3M
Gross Margin
Operating Margin
0.1%
14.1%
Net Margin
0.1%
11.2%
Revenue YoY
14.5%
1.1%
Net Profit YoY
20.7%
-12.0%
EPS (diluted)
$1.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
DOX
DOX
Q1 26
$1.9B
Q4 25
$1.6B
Q3 25
$1.5B
Q2 25
$1.7B
Q1 25
$1.6B
Q4 24
$1.5B
Q3 24
$1.6B
Q2 24
$1.5B
$1.3B
Net Profit
CME
CME
DOX
DOX
Q1 26
$1.2M
Q4 25
$1.2B
Q3 25
$908.0M
Q2 25
$1.0B
Q1 25
$956.2M
Q4 24
$874.6M
Q3 24
$912.8M
Q2 24
$883.2M
$140.3M
Operating Margin
CME
CME
DOX
DOX
Q1 26
0.1%
Q4 25
61.8%
Q3 25
63.3%
Q2 25
66.7%
Q1 25
67.5%
Q4 24
62.1%
Q3 24
64.6%
Q2 24
65.3%
14.1%
Net Margin
CME
CME
DOX
DOX
Q1 26
0.1%
Q4 25
71.7%
Q3 25
59.1%
Q2 25
60.6%
Q1 25
58.2%
Q4 24
57.3%
Q3 24
57.6%
Q2 24
57.6%
11.2%
EPS (diluted)
CME
CME
DOX
DOX
Q1 26
Q4 25
$3.24
Q3 25
$2.49
Q2 25
$2.81
Q1 25
$2.62
Q4 24
$2.40
Q3 24
$2.50
Q2 24
$2.42
$1.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
DOX
DOX
Cash + ST InvestmentsLiquidity on hand
$2.4B
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
Total Assets
$202.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
DOX
DOX
Q1 26
$2.4B
Q4 25
$4.5B
Q3 25
$2.6B
Q2 25
$2.1B
Q1 25
$1.5B
Q4 24
$3.0B
Q3 24
$2.4B
Q2 24
$1.9B
Total Debt
CME
CME
DOX
DOX
Q1 26
$3.4B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CME
CME
DOX
DOX
Q1 26
Q4 25
$28.7B
Q3 25
$28.2B
Q2 25
$27.7B
Q1 25
$27.0B
Q4 24
$26.5B
Q3 24
$28.2B
Q2 24
$27.6B
Total Assets
CME
CME
DOX
DOX
Q1 26
$202.0B
Q4 25
$198.4B
Q3 25
$187.1B
Q2 25
$179.9B
Q1 25
$157.8B
Q4 24
$137.4B
Q3 24
$137.8B
Q2 24
$123.4B

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons